Company Macrogen, Inc.

Equities

A038290

KR7038290003

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Macrogen, Inc.

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
19,350 ^KRW	-2.17%		-6.52%	-7.86%

2023	Tranche Update on Macrogen, Inc.'s Equity Buyback Plan announced on October 21, 2022.	CI
2023	Tranche Update on Macrogen, Inc.'s Equity Buyback Plan announced on October 21, 2022.	CI

Macrogen, Inc. is a Korea-based company mainly engaged in the customized transgenic and other services in the field of biomedical research. The Company operates its business through four divisions: deoxyribonucleic acid (DNA) sequencing division, DNA chips division, transgenic and knockout mouse division and oligonucleotide DNA division. Its DNA sequencing division provides genome sequencing analysis services. Its DNA chips division develops DNA chips products, such as Illumina chips, MacArray chips and customized chips. Its transgenic and knockout mouse division offers gene engineering services. Its oligonucleotide DNA division offers oligonucleotide DNA manufacturing services. The Company operates its business within domestic market and in overseas markets.

Number of employees: 532

KRW in Million	2022	Weight	2023	Weight	Delta
Next Generation Sequencing 55.6 %	76,516	55.2 %	73,879	55.6 %	-3.45%
Capillary Electrophoresis Sequencing 25.3 %	32,814	23.7 %	33,640	25.3 %	+2.52%
Others 9.0 %	16,188	11.7 %	11,929	9.0 %	-26.31%
Genome Applications 7.6 %	10,872	7.8 %	10,045	7.6 %	-7.61%
Clinical Diagnosis 2.5 %	2,227	1.6 %	3,309	2.5 %	+48.60%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 52.4 %	70,514	50.9 %	69,533	52.4 %	-1.39%
Europe 16.9 %	21,492	15.5 %	22,469	16.9 %	+4.54%
Other Countries 15.2 %	22,871	16.5 %	20,184	15.2 %	-11.75%
Japan 14.2 %	21,828	15.7 %	18,836	14.2 %	-13.71%
Australia 0.7 %	1,437	1.0 %	993	0.7 %	-30.95%
United States 0.6 %	474	0.3 %	790	0.6 %	+66.52%

Managers	Title	Age	Since
Su-Gang Lee CEO	Chief Executive Officer	58	-
Jong-Yeon Shin CTO	Chief Tech/Sci/R&D Officer	51	-
Chang-Hoon Kim BRD	Director/Board Member	57	-
Hyung-Tae Kim BRD	Director/Board Member	61	-
Han-Joon Bae SAM	Sales & Marketing	52	-
Eung-Ryong Lee PRN	Corporate Officer/Principal	51	-

Members of the board	Title	Age	Since
Jeong-Sun Seo CHM	Chairman	71	-
Hyung-Tae Kim BRD	Director/Board Member	61	-
Hee-Min Kwon BRD	Director/Board Member	72	-
Chang-Hoon Kim BRD	Director/Board Member	57	-
Jong-Il Kim BRD	Director/Board Member	57	-
Jin-Woo Park BRD	Director/Board Member	72	17-03-23
Su-Gang Lee CEO	Chief Executive Officer	58	-
Do-Ho Lee BRD	Director/Board Member	75	-
Young-Suk Yoo BRD	Director/Board Member	68	-
Ha-Young Park BRD	Director/Board Member	68	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,841,400	8,740,112 ( 80.62 %)	862,343 ( 7.954 %)	80.62 %

Name	Equities	%	Valuation
Jeong-Sun Seo 9.538 %	1,034,086	9.538 %	17 M ₩
MACROGEN, INC. 7.439 %	806,492	7.439 %	14 M ₩
National Pension Service of Korea 5.028 %	545,146	5.028 %	9 M ₩
Eun-wha Lee 0.6973 %	75,600	0.6973 %	1 M ₩
Soo-hyun Seo 0.6226 %	67,500	0.6226 %	1 M ₩
Macrogen, Inc. Employee Stock Ownership Association 0.0832 %	9,023	0.0832 %	151 137 ₩
Chang-Hoon Kim 0.0768 %	8,323	0.0768 %	139 412 ₩
Mirae Asset Global Investments Co., Ltd. 0.0517 %	5,602	0.0517 %	93 835 ₩
Dimensional Fund Advisors Ltd. 0.0308 %	3,335	0.0308 %	55 862 ₩
Eung-Ryong Lee 0.0197 %	2,133	0.0197 %	35 728 ₩

Name	Equities	%	Valuation
PSOMAGEN, INC. 36.81%	7,079,946	36.81%	27,557,203 $
MACROGEN, INC. 7.44%	806,492	7.44%	13,508,926 $
LABGENOMICS CO., LTD. 1.80%	1,335,288	1.80%	3,010,287 $
MICROBA LIFE SCIENCES LIMITED 3.98%	17,828,431	3.98%	2,442,495 $

Macrogen, Inc.

10/F, World Meridian Venture Center 254 Beotkkot-ro

08511, Seoul

http://www.macrogen.co.kr

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19,350 KRW

Average target price

30,000 KRW

Spread / Average Target

+55.04%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MACROGEN, INC.	-7.86%	143M
IQVIA HOLDINGS INC.	-1.42%	41.35B
LONZA GROUP AG	+42.15%	40.38B
MODERNA, INC.	+1.97%	39.05B
CELLTRION, INC.	-14.19%	26.67B
ICON PUBLIC LIMITED COMPANY	+1.82%	24.07B
ALNYLAM PHARMACEUTICALS, INC.	-24.55%	18.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-4.07%	11.68B
MEDPACE HOLDINGS, INC.	+21.36%	11.6B
UNITED THERAPEUTICS CORPORATION	+8.20%	11.15B

Other Biotechnology & Medical Research